Research & Reviews: A Journal of Pharmacognosy Original Research

Exploring the Therapeutic Potential of Phytochemicals in Aloe Barbadensis Miller Through Molecular Docking for Ulcerative Colitis Management

  1. Blessy Jacob Department of Pharmaceutical Chemistry, T John College of Pharmacy, Bengaluru
  2. Anusha K.B Department of Pharmaceutical Chemistry, T John College of Pharmacy, Bengaluru
  3. Vineeth Chandy T John College of Pharmacy, Bengaluru

Abstract

Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by mucosal inflammation of the colon, often associated with immune dysregulation and oxidative stress. Natural compounds have gained significant attention as alternative therapeutic agents due to their efficacy and minimal side effects. Quercetin, a flavonoid abundantly found in Allium cepa (onion), has demonstrated potent anti-inflammatory and antioxidant properties. This study employs an in silico approach to evaluate the therapeutic potential of quercetin as a modulator of key inflammatory pathways implicated in UC pathogenesis. Molecular docking studies were conducted to assess the binding affinity of quercetin against pivotal inflammatory targets such as TNF-α, IL-6, COX-2, and NF-κB. Additionally, ADME (Absorption, Distribution, Metabolism, and Excretion) profiling and drug-likeness evaluations were performed using SwissADME and pkCSM tools to determine its pharmacokinetic suitability. The docking results revealed favorable binding interactions of quercetin with all selected targets, suggesting its potential role in modulating inflammatory responses. Pharmacokinetic analyses indicated good oral bioavailability, high gastrointestinal absorption, and a low risk of toxicity. These findings suggest that quercetin from Allium cepa could be a promising natural therapeutic candidate for managing ulcerative colitis by targeting multiple inflammatory pathways. Further in vitro and in vivo investigations are warranted to validate these computational insights.

Keywords

References (19)

  1. Bahrami G, Malekshahi H, Miraghaee S, Madani H, Babaei A, Mohammadi B, et al. Protective and Therapeutic Effects of Aloe Vera Gel on Ulcerative Colitis Induced by Acetic Acid in Rats. Clinical Nutrition Research. 2020;9(3):223. doi:10.7762/cnr.2020.9.3.223
  2. Naini MA, Zargari-Samadnejad A, Mehrvarz S, Tanideh R, Ghorbani M, Dehghanian A, et al. Anti-Inflammatory, Antioxidant, and Healing-Promoting Effects of Aloe vera Extract in the Experimental Colitis in Rats. Evidence-Based Complementary and Alternative Medicine. 2021;2021:1-12. doi:10.1155/2021/9945244
  3. Maryam Akaberi, Zahra Sobhani, Behjat Javadi, Amirhossein Sahebkar, Seyed Ahmad Emami, Therapeutic effects of Aloe spp. in traditional and modern medicine: A review, Biomedicine & Pharmacotherapy, Volume 84, 2016, Pages 759-772.
  4. Arora A, Sharma N, Kakkar D. Natural polysaccharides for ulcerative colitis. Asian Pacific Journal of Tropical Biomedicine. 2023;13(5):185-194. doi:10.4103/2221-1691.377405
  5. Wan P. Advances in treatment of ulcerative colitis with herbs: From bench to bedside. World Journal of Gastroenterology. 2014;20(39):14099. doi:10.3748/wjg.v20.i39.14099
  6. Hamman JH. Composition and Applications of Aloe vera Leaf Gel. Molecules. 2008;13(8):1599-1616. doi:10.3390/molecules13081599
  7. Surjushe A, Vasani R, Saple D. Aloe vera: A short review. Indian Journal of Dermatology. 2008;53(4):163. doi:10.4103/0019-5154.44785
  8. Svitina H, Hamman J, Gouws C. Molecular mechanisms and associated cell signalling pathways underlying the anticancer properties of phytochemical compounds from Aloe species (Review). Experimental and Therapeutic Medicine. 2021;22(2). doi:10.3892/etm.2021.10284
  9. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry. 2009;30(16):2785-2791. doi:10.1002/jcc.21256
  10. Surjushe A, Vasani R, Saple DG. Aloe vera: a short review. Indian J Dermatol. 2008;53(4):163–166. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763764/
  11. Reynolds T, Dweck AC. Aloe vera leaf gel: a review update. Journal of Ethnopharmacology. 1999;68(1-3):3-37. doi:10.1016/s0378-8741(99)00085-9
  12. ESHUN K, HE Q. Aloe Vera: A Valuable Ingredient for the Food, Pharmaceutical and Cosmetic Industries—A Review. Critical Reviews in Food Science and Nutrition. 2004;44(2):91-96. doi:10.1080/10408690490424694
  13. Choi S, Chung MH. A review on the relationship between Aloe vera components and their biologic effects. Semin Integr Med. 2003;1(1):53–62. doi:10.1016/S1543-1150(03)00010-5
  14. BOUDREAU MD, BELAND FA. An Evaluation of the Biological and Toxicological Properties ofAloe Barbadensis(Miller), Aloe Vera. Journal of Environmental Science and Health, Part C. 2006;24(1):103-154. doi:10.1080/10590500600614303
  15. Zhang J, Ma S, Wang C, Guo G, Zhou L, Tian X, et al. Screening active constituents against ulcerative colitis by in silico, in vitro and in vivo approaches. Food Funct. 2018;9(10):5124–38. doi:10.1039/C8FO01439F.
  16. Lee HJ, Kim GH, Shim JH, Choi DH. Dietary quercetin alleviates DSS-induced colitis in mice by modulating key IBD-related pathways: transcriptome analysis. Bentham Sci. 2020;26:32651963. doi:10.2174/1874078X2021207300019.
  17. Li P, Zhang Y, Wang Z, Wang S. Biological activities underlying the therapeutic effects of quercetin on inflammatory bowel disease. Inflammopharmacology. 2022;30(1):23–38. doi:10.1007/s10787-021-00840-x.
  18. Ogunwa TH, Rotimi D, Salawu O. Systems pharmacology and docking analysis reveal β-sitosterol interactions with CA-II in inflammatory conditions. J Mol Graph Model. 2021;108:107975. doi:10.1016/j.jmgm.2021.107975.
  19. Jiang Y, Yan B, Qin K, Liu X, Duan X, Wang G, et al. Network pharmacology and molecular docking validate quercetin, luteolin, and nobiletin as key anti-UC compounds from Pimpinella candolleana. Front Pharmacol. 2024;15:1328977. doi:10.3389/fphar.2024.1328977.
Support